Aktis Oncology, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Certification of approval for listing and registration on a national securities exchange

Notice of Effectiveness

Amended Initial Registration Statement

Registration of Securities on Exchange

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

06b

Czibere Akos

Czibere Akos

Herrmann Ken

Herrmann Ken

Herrmann Ken

Herrmann Ken

Czibere Akos

Ron-Bigger Shulamit

Czibere Akos

Ron-Bigger Shulamit

Blue Owl Capital Holdings LP

Gormley Glenn

Gormley Glenn

EcoR1 Capital, LLC

MPM BIOVENTURES 2018, L.P.

ELI LILLY & Co

ELI LILLY & Co

Foley Todd

EVNIN LUKE; MPM ONCOLOGY INNOVATIONS FUND LP; MPM BIOVENTURES 2018 (B), L.P.; MPM BIOVENTURES 2018, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLC; MPM Oncology Innovations Fund GP LLC

GADICKE ANSBERT; Oncology Impact Private Investment Fund 2, L.P.; MPM ASSET MANAGEMENT LLC

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission)